{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:53:36Z","timestamp":1791579216896,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.rpth.2026.106965","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:21:52Z","timestamp":1789453312000},"page":"106965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of dual-pathway antithrombotic therapy with primary patency after iliofemoral venous stenting: a multicenter cohort study"],"prefix":"10.1016","volume":"10","author":[{"given":"Can","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daqiao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianzhou","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baolei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.106965_bib1","article-title":"Interventional treatment for post-thrombotic chronic venous obstruction: progress and challenges","volume":"12","author":"Barbati","year":"2024","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.rpth.2026.106965_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejvs.2024.10.002","article-title":"Prognostic value of a classification system for iliofemoral stenting in patients with chronic venous obstruction","volume":"69","author":"Jalaie","year":"2025","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.rpth.2026.106965_bib3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejvs.2022.11.006","article-title":"A systematic review of the safety and efficacy of inferior vena cava stenting","volume":"65","author":"Morris","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.rpth.2026.106965_bib4","article-title":"Outcomes following stenting for symptomatic chronic iliofemoral venous stenosis\u2014a comparison of three stent types","volume":"13","author":"Smith","year":"2025","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.rpth.2026.106965_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ejvs.2023.09.044","article-title":"Editor\u2019s choice\u2014management of lower extremity venous outflow obstruction: results of an international delphi consensus","volume":"67","author":"Black","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.rpth.2026.106965_bib6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/0268355520901661","article-title":"Use of anticoagulation therapy post deep venous stenting for post-thrombotic disease and non-thrombotic iliac vein lesions\u2014any consensus?","volume":"35","author":"Yap","year":"2020","journal-title":"Phlebology"},{"key":"10.1016\/j.rpth.2026.106965_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.002772","article-title":"Safety and effectiveness of stent placement for iliofemoral venous outflow obstruction: systematic review and meta-analysis","volume":"8","author":"Razavi","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.rpth.2026.106965_bib8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejvs.2021.12.024","article-title":"Editor\u2019s choice\u2014european society for vascular surgery (ESVS) 2022 clinical practice guidelines on the management of chronic venous disease of the lower limbs","volume":"63","author":"De Maeseneer","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.rpth.2026.106965_bib9","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jvsv.2021.02.012","article-title":"Early thrombosis after iliac stenting for venous outflow occlusion is related to disease severity and type of anticoagulation","volume":"9","author":"Marston","year":"2021","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.rpth.2026.106965_bib10","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jvsv.2020.10.011","article-title":"Stent characteristics of 32 patients with early (<14 days) iliofemoral stent occlusion","volume":"9","author":"Fu","year":"2021","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.rpth.2026.106965_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jvsv.2020.08.004","article-title":"Anticoagulation reduces iliocaval and iliofemoral stent thrombosis in patients with cancer stented for nonthrombotic venous obstruction","volume":"9","author":"Drabkin","year":"2021","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.rpth.2026.106965_bib12","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/jth.15197","article-title":"Postinterventional antithrombotic management after venous stenting of the iliofemoral tract in acute and chronic thrombosis: a systematic review","volume":"19","author":"Notten","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106965_bib13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ejvs.2018.01.007","article-title":"Antithrombotic therapy following venous stenting: international delphi consensus","volume":"55","author":"Milinis","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.rpth.2026.106965_bib14","article-title":"Principles of optimal antithrombotic therapy for iliac VEnous stenting (POATIVES): a national expert-based delphi consensus study","volume":"12","author":"Guo","year":"2024","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.rpth.2026.106965_bib15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1055\/s-0044-1786755","article-title":"Optimizing venous stenting: consensus recommendations for enhanced management of lower extremity deep vein thrombosis","volume":"50","author":"Trujillo-Santos","year":"2024","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2026.106965_bib16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1161\/CIRCULATIONAHA.124.073050","article-title":"Aspirin plus rivaroxaban versus rivaroxaban alone for the prevention of venous stent thrombosis among patients with post-thrombotic syndrome: the multicenter, multinational, randomized, open-label ARIVA trial","volume":"151","author":"Barco","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2026.106965_bib17","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106965_bib18","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.106965_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.124.014160","article-title":"Consensus statement on the management of nonthrombotic iliac vein lesions from the VIVA foundation, the American venous forum, and the American vein and lymphatic society","volume":"17","author":"Desai","year":"2024","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.rpth.2026.106965_bib20","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ejvs.2020.11.050","article-title":"Comparing safety and efficacy of rivaroxaban with warfarin for patients after successful stent placement for chronic iliofemoral occlusion: a retrospective single institution study","volume":"61","author":"Zhang","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.rpth.2026.106965_bib21","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1016\/j.jtha.2023.09.008","article-title":"Antithrombotic management of patients with deep vein thrombosis and venous stents: an international registry","volume":"21","author":"Lee Cervi","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106965_bib22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.thromres.2018.10.027","article-title":"Rivaroxaban or vitamin-K antagonists following early endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis","volume":"172","author":"Sebastian","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.106965_bib23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1177\/0268355515596289","article-title":"Combination of factor Xa inhibition and antiplatelet therapy after stenting in patients with iliofemoral post-thrombotic venous obstruction","volume":"31","author":"Langwieser","year":"2015","journal-title":"Phlebology"},{"key":"10.1016\/j.rpth.2026.106965_bib24","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jvir.2021.08.016","article-title":"Comparison of anticoagulation regimens following stent placement for nonthrombotic lower extremity venous disease","volume":"32","author":"Arendt","year":"2021","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.rpth.2026.106965_bib25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jvsv.2020.08.024","article-title":"Outcomes of endovascular venous stenting in patients on direct oral anticoagulants and antiplatelet therapy at a tertiary referral center","volume":"9","author":"Hays","year":"2021","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.rpth.2026.106965_bib26","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ejvs.2023.01.005","article-title":"Predictive factors of stent patency in iliofemoral venous diseases in a multicentre cohort study","volume":"65","author":"Espitia","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.rpth.2026.106965_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2024.109197","article-title":"Anticoagulation plus antiplatelet therapy versus anticoagulation alone following iliac vein stent implantation in acute and subacute deep vein thrombosis: a multicenter study with propensity score matching","volume":"244","author":"Qiu","year":"2024","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.106965_bib28","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa2519001","article-title":"Endovascular therapy for post-thrombotic syndrome\u2014a randomized trial","volume":"394","author":"Vedantham","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.106965_bib29","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1161\/CIRCULATIONAHA.118.033580","article-title":"Combination antiplatelet and oral anticoagulant therapy in patients with coronary and peripheral artery disease","volume":"139","author":"Gurbel","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2026.106965_bib30","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.106965_bib31","article-title":"Antiplatelet agents for the treatment of deep venous thrombosis","volume":"7","author":"Flumignan","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rpth.2026.106965_bib32","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00270-018-2062-5","article-title":"Antiplatelet therapy is associated with stent patency after iliocaval venous stenting","volume":"41","author":"Endo","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.rpth.2026.106965_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103440","article-title":"Arterial and venous thromboembolic events in patients with cancer treated with targeted therapies: a population-based cohort study","volume":"87","author":"Moik","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.rpth.2026.106965_bib34","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1001\/archinte.164.20.2260","article-title":"Venous thromboembolism according to age: the impact of an aging population","volume":"164","author":"Stein","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rpth.2026.106965_bib35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s00270-021-03038-2","volume":"45","author":"David","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.rpth.2026.106965_bib36","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4329\/wjr.v13.i12.371","article-title":"Prevalence of hypercoagulable states in stented thrombotic iliac vein compression syndrome with comparison of re-intervention and anticoagulation regimens","volume":"13","author":"Cramer","year":"2021","journal-title":"World J Radiol"},{"key":"10.1016\/j.rpth.2026.106965_bib37","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jvsv.2020.09.013","article-title":"Effect of thrombophilia on clinical outcomes of chronic post-thrombotic patients after iliofemoral stenting with nitinol venous stents","volume":"9","author":"Gwozdz","year":"2021","journal-title":"J Vasc Surg Venous Lymphat Disord"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247503792603623X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247503792603623X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:41:32Z","timestamp":1791578492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S247503792603623X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S247503792603623X"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106965","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of dual-pathway antithrombotic therapy with primary patency after iliofemoral venous stenting: a multicenter cohort study","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"106965"}}